{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:17:12Z","timestamp":1774124232171,"version":"3.50.1"},"reference-count":14,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"ACS-5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.14745\/ccdr.v36i00a05","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T14:38:57Z","timestamp":1520001537000},"page":"1-22","source":"Crossref","is-referenced-by-count":17,"title":["Recommendations on Interferon Gamma Release Assaysfor the Diagnosis of Latent Tuberculosis Infection\u20142010 Update"],"prefix":"10.14745","volume":"36","author":[{"given":"Dennis","family":"Kunimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drs Michael","family":"Gardam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Morshed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhukar","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Wobeser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5795","published-online":{"date-parts":[[2010,6]]},"reference":[{"key":"key20180302093845_r1","first-page":"1","article-title":"Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS)","volume":"33","author":"Canadian Tuberculosis Committee","year":"2007","journal-title":"Can Commun Dis Rep"},{"key":"key20180302093845_r2"},{"key":"key20180302093845_r3","first-page":"1","article-title":"Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS)","volume":"34","author":"Canadian Tuberculosis Committee (CTC)","year":"2008","journal-title":"Can Commun Dis Rep"},{"issue":"5","key":"key20180302093845_r4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","year":"2007","journal-title":"Ann Intern Med"},{"issue":"3","key":"key20180302093845_r5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","year":"2008","journal-title":"Ann Intern Med"},{"issue":"10","key":"key20180302093845_r6","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","article-title":"Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis","volume":"177","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"key20180302093845_r7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1440-1843.2006.01000.x","article-title":"Use of QuantiFERON-TB Gold to investigate tuberculosis contacts in a high school","volume":"12","year":"2007","journal-title":"Respirology"},{"issue":"1","key":"key20180302093845_r8","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis","volume":"11","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"key20180302093845_r9","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"key20180302093845_r10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","year":"2008","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"key20180302093845_r11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"key20180302093845_r12","first-page":"153","article-title":"Use of incentives to increase compliance for TB screening in a population of intravenous drug users","volume":"3","author":"Vancouver Injection Drug Use Study Group","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"key20180302093845_r13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1473-3099(07)70086-5","article-title":"T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward","volume":"7","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"key20180302093845_r14","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","article-title":"Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?","volume":"4","year":"2007","journal-title":"PLoS Med"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/10pdf\/36-acs-5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T18:40:56Z","timestamp":1521744056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/10pdf\/36-acs-5.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":14,"journal-issue":{"issue":"ACS-5","published-online":{"date-parts":[[2010,6]]},"published-print":{"date-parts":[[2010,6]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v36i00a05","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}